Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vacci... Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. Show more
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced that notice has been provided of the mutual exercise of an option to...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00...
If approved by the European Commission, WINREVAIR will be the first activin signaling inhibitor therapy for PAH in Europe, offering a new treatment option for certain adults with this rare...
CAPVAXIVE (V116) recommended for all adults age 65 and older and for adults 19 to 64 with certain risk conditions, and for those over 65 previously vaccinated with other pneumococcal vaccines...
Interactive Brokers (NASDAQ:IBKR) – Interactive Brokers revealed a loss of $48 million due to an error on the New York Stock Exchange that temporarily showed a 99% drop in the stock prices...
The letter did not identify any issues with the efficacy or safety data submitted in the application The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for...
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease Merck Animal Health, known as MSD Animal Health outside of the United States and...
Fisker (NYSE:FSR) – The American electric vehicle manufacturer filed for bankruptcy last night, aiming to sell its assets and restructure debts following severe financial challenges in the...
CAPVAXIVE (V116) is specifically designed for adults and covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults 50 years of age and older Across four Phase...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -6.35 | -4.7619047619 | 133.35 | 134.63 | 120.87 | 19127070 | 126.37113709 | CS |
4 | -0.76 | -0.594865372574 | 127.76 | 134.63 | 120.87 | 10874182 | 128.41918906 | CS |
12 | 0.24 | 0.189334174819 | 126.76 | 134.63 | 120.87 | 8525627 | 128.23269594 | CS |
26 | 17.76 | 16.2577810326 | 109.24 | 134.63 | 109.16 | 8539601 | 125.63037773 | CS |
52 | 12.09 | 10.5212775215 | 114.91 | 134.63 | 99.14 | 7991891 | 116.28035931 | CS |
156 | 48.96 | 62.737057919 | 78.04 | 134.63 | 70.89 | 9709976 | 96.85251853 | CS |
260 | 42.54 | 50.367037651 | 84.46 | 134.63 | 65.25 | 9935135 | 89.87344193 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.